~~<i id='5D5A8F1034'><strike id='5D5A8F1034'><tt id='5D5A8F1034'><pre id='5D5A8F1034'></pre></tt></strike></i>~~

Home» knowledge» leisure time

leisure time

author：Wikipedia 2025-09-30 13:54:27 Page View：51442

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Lack of health data on LGBTQ+ people has serious consequences
Next article： The cancer drug shortage isn’t new — and neither are the solutions

explore

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

Here’s what’s in the FDA plan to include pregnant women in clinical trials

AdobeTheFDAhastakenabigstepinencouragingdrugcompaniestoincludepregnantwomeninclinicaltrials,issuinga

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Immune cells and nerve overgrowth may explain recurring UTI pain

AmastcellAdobeEachyear,morethan400millionurinarytractinfectionsoccurinpeoplearoundtheglobe.Andresear